Research Analysts Set Expectations for ALHC FY2027 Earnings

Key Points

• KeyCorp forecasts that Alignment Healthcare will post an EPS of $0.37 for FY2027, with a current target price of $21.00 and an "Overweight" rating.
• Alignment Healthcare's stock has received varied ratings, with one analyst rating it a "Strong Buy," while six have issued a "Buy" rating and four a "Hold" rating, resulting in a consensus rating of "Moderate Buy."
• The company recently reported an earnings surprise with EPS of $0.07 for the last quarter, exceeding expectations of a negative EPS and showing a 49.0% revenue growth year-over-year.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) - KeyCorp issued their FY2027 earnings per share estimates for Alignment Healthcare in a note issued to investors on Sunday, August 24th. KeyCorp analyst M. Gillmor anticipates that the company will post earnings per share of $0.37 for the year. KeyCorp currently has a "Overweight" rating and a $21.00 target price on the stock. The consensus estimate for Alignment Healthcare's current full-year earnings is ($0.69) per share.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The firm had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. During the same period last year, the firm earned ($0.13) earnings per share. The company's revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.

Several other analysts have also recently issued reports on the company. Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen cut Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Finally, Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Trading Up 0.2%

Shares of NASDAQ ALHC traded up $0.04 during trading hours on Tuesday, hitting $16.36. The company's stock had a trading volume of 1,760,791 shares, compared to its average volume of 2,874,104. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market cap of $3.24 billion, a price-to-earnings ratio of -58.43 and a beta of 1.17. Alignment Healthcare has a 12 month low of $8.65 and a 12 month high of $21.06. The business has a 50-day simple moving average of $13.93 and a 200-day simple moving average of $15.35.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, Director Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $16.00, for a total transaction of $400,000.00. Following the sale, the director directly owned 1,152,049 shares of the company's stock, valued at approximately $18,432,784. The trade was a 2.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Hyong Kim sold 24,800 shares of Alignment Healthcare stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $16.00, for a total value of $396,800.00. Following the sale, the insider directly owned 447,367 shares in the company, valued at approximately $7,157,872. The trade was a 5.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 636,185 shares of company stock worth $9,235,468. Insiders own 6.60% of the company's stock.

Hedge Funds Weigh In On Alignment Healthcare

Several large investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock valued at $206,941,000 after purchasing an additional 1,295,825 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Alignment Healthcare by 5.0% during the first quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company's stock valued at $169,035,000 after purchasing an additional 429,071 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Alignment Healthcare by 0.9% during the first quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company's stock valued at $139,819,000 after purchasing an additional 70,557 shares during the last quarter. Hood River Capital Management LLC lifted its holdings in shares of Alignment Healthcare by 6.0% during the second quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company's stock valued at $77,243,000 after purchasing an additional 311,424 shares during the last quarter. Finally, 8 Knots Management LLC lifted its holdings in shares of Alignment Healthcare by 6.4% during the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company's stock valued at $70,222,000 after purchasing an additional 300,409 shares during the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.